stocks
Profits over patients: US pharma spending billions on investor payouts
June 2, 2021Research and Development Trump, US, stocks
In 2017 Donald Trump signed the Tax Cuts and Jobs Act (TCJA), creating billions of dollars in tax rate cuts …
ImmunoGen shares plummet by 32% after FDA recommends new Phase 3 trial
May 16, 2019Business Services, Research and Development Cancer, Immunogen, Shares, ovarian cancer, pharma, stocks
Shares in ImmunoGen fell 32% in premarket trading after the firm said the FDA had recommended a new Phase 3 …
Shares in Mirati plummet after disappointing Phase II trial
October 23, 2018Manufacturing and Production Cancer, Mirati, leuakemia, plummet, stocks
Shares in the California-based biotech Mirati Therapuetics plummeted on Monday after the company released disappointing results from their Phase II …
Shares in Molecular Templates surge after the announcement of Takeda collaboration
September 20, 2018Business Services, Research and Development Molecular Templates, Shares, Takeda, markets, stocks
Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with …
Weekly Movers: Medivation, Bind Therapeutics, Insys…
July 11, 2016Manufacturing and Production, Research and Development, Sales and Marketing Medivation, XBiotech, juno therapeutics, markets, stocks
Medivation (Nasdaq: MDVN) stock rose after the company announced it has entered a confidentiality agreement with a number of parties …
Weekly Movers: Regulus, Nymox, Akers…
July 4, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shares, drug trial, markets, stocks
Shares in Regulus Therapeutics (Nasdaq: RGLS) dropped after the company said it has received verbal notification from the US Food …
Weekly Movers: Global Blood Therapeutics, Sophiris Bio…
June 20, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks
Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …
Weekly Movers: Array BioPharma, Amicus Therapeutics, Genocea Biosciences, Tesaro Inc, Incyte, Clovis Oncology
April 11, 2016Manufacturing and Production, Research and Development, Sales and Marketing Index, Movers, markets, stocks
Shares in Botox-maker Allergan (NYSE: AGN) plunged over 17% in intra-day trading as the $160 billion merger seal with US …
InVivo Therapeutics to sell stake in company; shares drop
March 15, 2016Business Services, Manufacturing and Production, Research and Development, Sales and Marketing InVivo Therapeutics, Stake sale, stocks
InVivo Therapeutics (Nasdaq: NVIV) said it plans to sell an additional stake in the company to raise funds for its ongoing …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
